Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult

Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult

10.1634/stemcells.2007-0061

Saved in:

Bibliographic Details
Main Authors:	Motoda, L., Osato, M., Yamashita, N., Jacob, B., Chen, L.Q., Yanagida, M., Ida, H., Wee, H.-J., Sun, A.X., Ito, Y., Taniuchi, I., Littman, D.
Other Authors:	MEDICINE
Format:	Article
Published:	2012
Subjects:	AML1 c-Kit FLT3 Runx Senescence
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/30180
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult
by: Motoda, L., et al.
Published: (2011)

Runx1/AML1 is a guardian of hematopoietic stem cells
by: Motoda, L., et al.
Published: (2012)

Oncogenic potential of the RUNX gene family: 'Overview'
by: Ito, Y.
Published: (2014)

Oncogenic potential of the RUNX gene family: 'Overview'
by: Ito, Y.
Published: (2016)

Increased dosage of the RUNX1/AML1 gene: A third mode of RUNX leukemia?
by: Osato, M., et al.
Published: (2011)

Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice
by: Ito, Y., et al.
Published: (2011)

Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice
by: Ito, Y., et al.
Published: (2012)

Point mutations in the RUNX1/AML1 gene: Another actor in RUNX leukemia
by: Osato, M.
Published: (2011)

RUNX1 meets MLL: Epigenetic regulation of hematopoiesis by two leukemia genes
by: Koh, C.P., et al.
Published: (2014)

ROLES OF CBFB DEFICIENCY AND RUNX1 HAPLOINSUFFICIENCY ON HEMATOPOIESIS
by: CHIN WAI LOON DESMOND
Published: (2015)

Dual mutations in the AML1 and FLT 3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype
by: Matsuno, N., et al.
Published: (2011)

Stem cell exhaustion and leukemogenesis
by: Jacob, B., et al.
Published: (2014)

RUNX3 functions as an oncogene in ovarian cancer
by: Lee, C.W.L., et al.
Published: (2014)

Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
by: Hart, S., et al.
Published: (2014)

A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells
by: Ng, C.E.L., et al.
Published: (2014)

The multiple interactions of RUNX with the hippo–YAP pathway
by: Chuang, Linda Shyue Huey, et al.
Published: (2022)

Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein
by: Inoue, K.-I., et al.
Published: (2016)

Down-regulation of RUNX1, RUNX3 and CBFβ in hepatocellular carcinomas in an early stage of hepatocarcinogenesis
by: Miyagawa, K., et al.
Published: (2012)

Down-regulation of RUNX1, RUNX3 and CBFβ in hepatocellular carcinomas in an early stage of hepatocarcinogenesis
by: Miyagawa, K., et al.
Published: (2011)

Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
by: Yanagida, M., et al.
Published: (2011)

FUS MODULATES RUNX1-MEDIATED TRANSCRIPTION VIA PHASE SEPARATION TO MAINTAIN CELLULAR INTEGRITY IN HEMATOPOIETIC STEM CELLS AND LYMPHOID PROGENITORS
by: BIBEK DUTTA
Published: (2022)

Roles of RUNX3 as a tumor supressor protein
by: LEE WEI LIN
Published: (2011)

Runx family genes, niche, and stem cell quiescence
by: Wang, C.Q., et al.
Published: (2014)

Aurora kinase-induced phosphorylation excludes transcription factor RUNX from the chromatin to facilitate proper mitotic progression
by: Chuang, Linda Shyue Huey, et al.
Published: (2017)

Genetic evidence of PEBP2β-independent activation of Runx1 in the murine embryo
by: Yokomizo, T., et al.
Published: (2011)

Genetic evidence of PEBP2β-independent activation of Runx1 in the murine embryo
by: Yokomizo, T., et al.
Published: (2012)

Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer
by: Sakakura, C., et al.
Published: (2011)

RUNX3 interactome reveals novel centrosomal targeting of RUNX family of transcription factors
by: Chuang, L.S.H., et al.
Published: (2014)

CORE BINDING FACTOR FUSION DOWNREGULATION OF ADAR2 RNA EDITING CONTRIBUTES TO AML LEUKEMOGENESIS
by: GUO MINGRUI
Published: (2022)

RAS oncogenic signal upregulates EZH2 in pancreatic cancer
by: Fujii, S., et al.
Published: (2016)

Molecular pathology of RUNX3 in human carcinogenesis
by: Subramaniam, M.M., et al.
Published: (2012)

Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
by: Huang, C., et al.
Published: (2011)

Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
by: Huang, C., et al.
Published: (2012)

Identification of additional genetic alterations in RUNX1 related leukemias
by: BINDYA JACOB
Published: (2011)

Runx3 -/- gastric epithelial cells differentiate into intestinal type cells
by: Fukamachi, H., et al.
Published: (2014)

Runx3-/-gastric epithelial cells differentiate into intestinal type cells
by: Fukamachi, H., et al.
Published: (2011)

Runx3 expression in gastrointestinal tract epithelium: Resolving the controversy
by: Ito, K., et al.
Published: (2011)

Parkinsonism as an unusual presenting symptom of pineal gland teratoma
by: Tan, R.M., et al.
Published: (2016)

Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol
by: Tan, R.M., et al.
Published: (2011)

RUNX family: Regulation and diversification of roles through interacting proteins
by: Chuang, L.S.H., et al.
Published: (2014)